Cargando…
Association of immune‐related expression profile with sensitivity to chemotherapy in esophageal squamous cell carcinoma
Neoadjuvant chemotherapy (NAC) followed by surgery is one of the standard therapeutic approaches in Japan for patients with locally advanced esophageal carcinoma. Recently, the JCOG1109 study revealed that NAC with docetaxel, cisplatin and 5‐fluorouracil (5‐FU) (DCF‐NAC) is superior to NAC with cisp...
Autores principales: | Tsukamoto, Yoshiyuki, Kurogi, Shusaku, Fujishima, Hajime, Shibata, Tomotaka, Fumoto, Shoichi, Nishiki, Kohei, Suzuki, Kosuke, Etoh, Tsuyoshi, Shiraishi, Norio, Fuchino, Takafumi, Hirashita, Yuka, Nakada, Chisato, Uchida, Tomohisa, Inomata, Masafumi, Moriyama, Masatsugu, Hijiya, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637075/ https://www.ncbi.nlm.nih.gov/pubmed/37715346 http://dx.doi.org/10.1111/cas.15942 |
Ejemplares similares
-
Patient-Derived Ex Vivo Cultures and Endpoint Assays with Surrogate Biomarkers in Functional Testing for Prediction of Therapeutic Response
por: Tsukamoto, Yoshiyuki, et al.
Publicado: (2023) -
A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer
por: Fujishima, Hajime, et al.
Publicado: (2017) -
Positron emission tomography complete metabolic response as a favorable prognostic predictor in esophageal cancer following neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil
por: Suzuki, Kosuke, et al.
Publicado: (2021) -
Downregulation of dual‐specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas
por: Ichimanda, Michihiro, et al.
Publicado: (2017) -
Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor
por: Amada, Kohei, et al.
Publicado: (2023)